What is Raily Aesthetic Medicine International Holdings Revenue per Share?
Raily Aesthetic Medicine International Holdings's revenue per share for the
six
months ended in Jun. 2023 was HK$0.22.
Raily Aesthetic Medicine International Holdings's revenue per share for the trailing twelve months (TTM) ended in Jun. 2023 was HK$0.43.
Warning Sign:
Raily Aesthetic Medicine International Holdings Ltd revenue per share has been in decline over the past 3 years.
During the past 12 months, the average Revenue Per Share Growth Rate of Raily Aesthetic Medicine International Holdings was -19.30% per year.
During the past 3 years, the average Revenue Per Share Growth Rate was -5.30% per year.
During the past 5 years, the average Revenue Per Share Growth Rate was 6.70% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate.
HKSE:02135'
s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -5.3 Med: 7.9 Max: 20.4
Current: -5.3
During the past 7 years, Raily Aesthetic Medicine International Holdings's highest 3-Year average Revenue Per Share Growth Rate was 20.40% per year. The lowest was -5.30% per year. And the median was 7.90% per year.
HKSE:02135's 3-Year Revenue Growth Rate is ranked worse than 84.33% of 587
companies
in the Healthcare Providers & Services industry
Industry Median: 9.7
vs HKSE:02135: -5.30
Raily Aesthetic Medicine International Holdings Revenue per Share Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Raily Aesthetic Medicine International Holdings Revenue per Share Chart
Raily Aesthetic Medicine International Holdings Annual Data
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Raily Aesthetic Medicine International Holdings's PS Ratio Distribution in the Healthcare Providers & Services Industry
* The bar in red indicates where Raily Aesthetic Medicine International Holdings's PS Ratio falls into.
Raily Aesthetic Medicine International Holdings Revenue per Share Calculation
Revenue per Share is the amount of Revenue per outstanding share of the company's stock.
Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.
Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$0.43
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Raily Aesthetic Medicine International Holdings (HKSE:02135) Revenue per Share Explanation
In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.
Peter Lynch categorized companies according to their revenue growth:
His favorite companies are stalwart, those growing between 10-20% a year.
Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.
Be Aware
Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.
Raily Aesthetic Medicine International Holdings Revenue per Share Related Terms
Thank you for viewing the detailed overview of Raily Aesthetic Medicine International Holdings's Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.
Raily Aesthetic Medicine International Holdings (HKSE:02135) Business Description
Raily Aesthetic Medicine International Holdings Ltd is an aesthetic medical service provider in Zhejiang Province, the PRC. It offers a broad range of aesthetic medical services to clients to meet their different aesthetic and anti-aging objectives. The group is organized into business units based on their services and has three reportable operating segments namely Aesthetic medical services which comprise principally inpatient services including surgical services and outpatient services including injection service, dermatology services, and others; and Consulting service segment which comprise principally management consulting services. Aesthetic medical equipment products comprise principally sales of surgical implants and aesthetic medical skincare products.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HKSE:02135 has been successfully added to your 